Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT

AJ Kanack, A Bayas, G George… - Blood, The Journal …, 2022 - ashpublications.org
Kanack and colleagues analyze anti-platelet factor 4 antibodies from 5 patients with vaccine-
induced thrombotic thrombocytopenia (VITT) secondary to COVID-19 adenoviral vaccination …
被引用次数：38 相关文章

Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT.

AJ Kanack, A Bayas, G George, MY Abou-Ismail… - Blood, 2022 - europepmc.org
Kanack and colleagues analyze anti-platelet factor 4 antibodies from 5 patients with vaccine-
induced thrombotic thrombocytopenia (VITT) secondary to COVID-19 adenoviral vaccination …
[HTML] nih.gov

[HTML][HTML] Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT

AJ Kanack, A Bayas, G George, MY Abou-Ismail… - Blood, 2022 - ncbi.nlm.nih.gov
Recently developed vaccines have produced salutary effects on hospitalizations and deaths
related to SARS-CoV-2 (COVID-19). 1 Two vaccines, ChAdOx1 nCoV-19 (AstraZeneca) and …

[引用][C] Monoclonal and oligoclonal anti-Platelet Factor 4 antibodies mediate VITT

A Kanack, A Bayas, G George, MY Abou-Ismail… - 2022 - opus.bibliothek.uni-augsburg.de
OPUS 4 | Monoclonal and oligoclonal anti-Platelet Factor 4 antibodies mediate VITT Deutsch
Login Open Access Home Search Browse Publish/report a document Help Monoclonal and …

Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT

AJ Kanack, A Bayas, G George, MY Abou-Ismail… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Kanack and colleagues analyze anti-platelet factor 4 antibodies from 5 patients with vaccine-
induced thrombotic thrombocytopenia (VITT) secondary to COVID-19 adenoviral vaccination …
[PDF] sciencedirect.com

[PDF][PDF] Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT

AJ Kanack, A Bayas, G George, MY Abou-Ismail… - Blood, 2022 - Elsevier
Recently developed vaccines have produced salutary effects on COVID-19-related
hospitalizations and deaths1. Two vaccines, ChAdOx1nCoV-19 (AstraZeneca) and Ad26 …

Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT.

AJ Kanack, A Bayas, G George, MY Abou-Ismail… - Blood, 2022 - europepmc.org
Kanack and colleagues analyze anti-platelet factor 4 antibodies from 5 patients with vaccine-
induced thrombotic thrombocytopenia (VITT) secondary to COVID-19 adenoviral vaccination …